Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Carcinoma, Renal Cell 4Kidney Neoplasms 3Ovarian Neoplasms 2Melanoma 2Lymphoma 2Fallopian Tube Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 1Sezary Syndrome 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Leukemia 1HTLV-I Infections 1Cholangiocarcinoma 1Carcinoma, Ovarian Epithelial 1Carcinoma 1

Interventions

peginterferon alfa-2b 1Zidovudine 1Valproic Acid 1Nivolumab 1Interferon alpha-2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × HTLV-I Infections × peginterferon alfa-2b × Clear all
NCT00854581 2018-04-17

Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma

University of Miami

Phase 4 Terminated
13 enrolled 15 charts
LymphoidOther hematologic neoplasmOther neoplasm

Lymphoma, Precancerous Conditions, HTLV-I Infections, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡